Remicade (infliximab) - J&J
Benlysta (belimumab) - GSK
hydroxychloroquine - Generic mfg.
Taltz (ixekizumab) - Eli Lilly, Japan Tobacco
Bimzelx (bimekizumab-bkzx) - UCB
Cimzia (certolizumab pegol) - Astellas, UCB
Rituxan (rituximab) - Roche
Humira (adalimumab) - AbbVie
Tremfya (guselkumab) - J&J
tofacitinib - Generic mfg.
Kineret (anakinra) - SOBI
Cosentyx (secukinumab) - Novartis
sulfasalazine - Generic mfg.
Stelara (ustekinumab) - J&J
cyclosporine - Generic mfg.
Ilaris (canakinumab) - Novartis
leflunomide - Generic mfg.
Skyrizi (risankizumab-rzaa) - AbbVie, Boehringer Ingelheim
Simponi (golimumab) - J&J
Rinvoq (upadacitinib) - AbbVie
Actemra IV (tocilizumab) - Roche, JW Pharma
Orencia (abatacept) - BMS
azathioprine - Generic mfg.
mycophenolate mofetil - Generic mfg.
Enbrel (etanercept) - Pfizer, Amgen
http://clinicaltrials.gov/ct2/show/NCT07138898
 
Aug 26, 2025
 
Next